OPIOIDERGIC AND SEROTONINERGIC CONTROL OF HEMATOPOIESIS AND IMMUNITY
Main researcher
: BORANIĆ, MILIVOJ (4493) Assistants
ŠTAMBUK, NIKOLA (160463)
KRIŽANAC-BENGEZ, LJILJANA (157383)
STANOVIĆ, SILVANA (900552)
BRELJAK, DAVORKA (900729)
Type of research: basic Duration from: 06/01/91. to 12/31/93. Papers on project (total): 56
Papers on project quoted in Current Contents: 16
Institution name: Institut "Ruđer Bošković", Zagreb (98) Department/Institute: Experimental Biology and Medicine (EBM) Laboratory for Experimental Hematology, Immunology and Oncology Address: Bijenička cesta 54, p.p. 1016 City: 10000 - Zagreb, Croatia
Communication
Phone: 385 (01) 45 61 011; 45 61 111
Fax: 385 (01) 425-497
E-mail: boranic@olimp.irb.hr
Summary: RESULTS 1994/5 In clonal cultures of mouse bone marrow
cells, opioid antagonist naloxone partly blocked the suppressive effect of
methionine-enkephalin on the generation of granulocyte-macrophage (GM)
colonies. In the long-term culture, naloxone inhibited cell proliferation,
particularly of the granulocyte lineage. On the other hand, thiorphan - an
inhibitor of the membrane-bound enzyme cleaving the enkephalins and
related neuropeptides (EC3.4.24.11, 'enkephalinase') stimulated the
proliferation of the granulocytic lineage cells in the long-term cultures
of mouse bone marrow. In the model system of humoral immune reaction in
vitro (mouse spleen cells stimulated with sheep erythrocytes as the
antigen), neurotransmitter serotonin inhibited the generation of
hemolyzin-producing cells (PFC). The inhibition was partly blocked by
serotonin antagonists ketanserine and propranolol. In continuous cultures
of neoplastically transformed lymphoid cells (myelomas, hybridomas),
serotonin in some concentrations stimulated the cell proliferation, in
contrast to its inhibition of normal cells. Serotonin antagonists did not
block the stimulatory effect. Comparative analysis of intraocular and
intrathecal IgG response in aqueous humor and cerebrospinal fluid has been
performed by means of immunochemical methods (detection of oligoclonal
IgG, total IgG, IL-4, beta-2-microglobulin, C3, C4) and by numerical
models of protein/IgG synthesis. The optimal parameters and models to
define the intraocular and intrathecal IgG response in physiological and
pathological conditions have been derived. In the long-term culture of
dog bone marrow cells, monoclonal antibody S5 which recognizes the
adhesion molecules (CD44) on the membranes of hematopoietic cells promoted
the generation of granulocyte-macrophage precursors (GM-CFU) with
concomitant decrease of nonadherent (mature) cells. The expression of the
MHC class II cell surface marker was enhanced. In addition, S5 enhanced
the expression of CD8 and VLA4 on small (lymphoid) cells, and the
expression of CD4 and CD18 on large (blast) cells. The NK-cell activity was
stimulated. Peripheral blood lymphocyte cultures of the patients with
encephalomyelitis or uveitis, as well as the lymphocytes of helathy
control persons, were cultured in the presence of peptide M. This peptide
is an antigenic fragment isolated from the retina and the pineal gland.
Lymphocyte sensitization to the peptide was observed in the patients'
samples. In short-term lymphocyte cultures, peptide M decreased the number
of chromosomal aberrations.
Research goals: Participation of opioidergic and serotoninergic
signals in the control of hematopoiesis and immunity, respectively, was
investigated using in vivo and in vitro model systems. Opioid peptides
were known to affect lymphocyte, macrophage and granulocyte functions, as
well as the proliferation of mesenchymal cells. It was postulated,
therefore, that enkephalins would affect the proliferation and
differentiation of cells in the hematopoietic tissue. The results were
expected (a) to confirm and further the recognition of the regulatory role
of signal molecules (mediators) shared by the central nervous,
hematopoietic and immune systems, and (b) to support the view that
hematopoiesis is not a self-contained process regulated by local
mechanisms only (growth factors, cellular interactions), but also receives
macroregulatory, systemic neuroendocrine signals. The specificity of
opioidergic signals in hematopoiesis was tested using an opioid
antagonist, naloxone; their dependence on cellular interactions, by
working with purified cell populations; and the role of the opioid
peptide-degrading enzyme D10, by using its specific inhibitor, thiorphan.
In order to investigate the role of cell surface adherent molecules (CD44)
in the control of cell proliferation and differentiation, hematopoietic
cell cultures were treated with specific anti-CD44 monoclonal antibody.
Experiments comparing the effects of serotonin on the immune response
and on the myeloma/hybridoma cell lines were intended to show whether
serotonin inhibits the response by diminishing the cell proliferation, or
interferes with other functions. The use of serotonin antagonists was
expected to reveal specificity of the serotonin effects, i.e. the presence
of 5HT receptors on the cells involved. In patients with autoimmune
encephalomyelitis or uveitis, sensitivity to peptide M (isolated from the
retina and the pineal gland) was explored. Definition of optimal
models for intraocular and intrathecal immune responses was attempted by
mathematical modelling.
COOPERATION - PROJECTS
Name of project
: > Haematologische und immunologische
Untersuchungen von Leukaemie--Erkrankungen verschidener Genese (Leukemia,
immunotherapeutic Models) Name of institution: GSF-Forschungzentrum fuer Umwelt und Gesundheit
GmbH, Institut fuer Immunologie City: D-8000 - Muenchen, SR Njemačka
Name of project
: Peptide M tolerization in multiple sclerosis
model Name of institution: Institut fuer Immunologie und Thymusforschung City: Bad Harzburg, Njemačka / Deutschland
Name of project
: Peptide M tolerization in uveitis model Name of institution: Institut fuer Immunologie und Thymusforschung City: Bad Harzburg, Njemačka / Deutschland
COOPERATION - INSTITUTIONS
Name of institution
: Institut fuer Immunologie der Gesellschaft
fuer Strahlen- und Umweltforschung GmbH City: D-8000 - Muenchen, SR Njemačka
Name of institution
: Fred Hutchinson Cancer Resarch Center,
Clinical Research Division Type of institution: University/Faculty City: WA 98104 - Seattle, SAD
Name of institution
: Institut fiziologii Russkoj akademii nauk City: Novosibirsk, Rusija
Name of institution
: Institut fuer Immunologie und
Thymusforschung Type of institution: Economical/Production Type of cooperation: Joint project Other information about the project.